Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Three new date values (2026-07-06, 2026-07-02, 2026-07) were added to the page, representing recent update timestamps in the study record.
    Difference
    0.1%
    Check dated 2026-07-10T17:14:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new page revision label v3.6.3 was added and the previous v3.6.2 label was removed, indicating a newer revision of the page metadata.
    Difference
    0.0%
    Check dated 2026-07-03T13:37:05.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous Revision: v3.6.0 on the page. This update reflects a change to the study record's documentation rather than the study content.
    Difference
    0.0%
    Check dated 2026-06-26T11:47:19.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Enrollment status updated to No longer looking for participants and new user-help sections added; study section headings updated (Intervention/Treatment) with a new revision tag (Revision: v3.6.0) and dates.
    Difference
    0.3%
    Check dated 2026-06-12T01:17:37.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4 on the page, indicating a new version of the page without substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-04T16:45:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s revision label has been updated from v3.5.3 to v3.5.4, indicating a newer build of the page. This update reflects a version change rather than a substantive alteration to the study details.
    Difference
    0.0%
    Check dated 2026-05-21T08:43:17.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.